Skip to content

Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00001503
Enrollment
1031
Registered
1999-11-04
Start date
1996-09-19
Completion date
2023-06-15
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Lymphoma, Melanoma, Ovarian Cancer, Prostate Cancer

Keywords

Cancer, Late-effects, Survival, Follow-Up, Natural History

Brief summary

This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.

Detailed description

Background: * Patients enrolled on CCR clinical protocols may require long term follow-up to assess outcome (e.g., survival) or the effects of prior therapy. * Keeping the primary treatment protocols open after accrual is complete in order to follow patients for long term outcome is an administrative burden on investigators and the IRB. Objectives: -To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol. Eligibility: -Patients who were previously enrolled on a CCR protocol and who are not eligible for an active NCI intramural primary research protocol. Design: * The medical procedures/tests will be based on the patient's diagnosis, treatment and supporting clinical information. This is a follow-up study in which only standard tests and procedures are to be performed. * Clinical information that is relevant to the patients prior protocols will be collected for research purposes. * Procedures that entail more than minimal risk to the patient should not be performed for research purposes on this protocol.

Interventions

None listed

Sponsors

National Cancer Institute (NCI)
Lead SponsorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* ELIGIBILITY CRITERIA: Patients of any age who were previously enrolled on a CCR protocol. Not eligible for or unwilling to participate in an active NCI intramural primary research protocol. CCR investigator decides it is in the best interests of the patient and the CC for the patient to be seen in follow-up visits at the NIH. Patient or Legally Authorized Representative (LAR)/guardian is able to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol30 yearsProvision of a mechanism to follow selected CCR patients when their protocols have been terminated.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026